Evidence mapPaperPMID 41969487Full record

ArticleTranslational cancer research2026

A ferroptosis-related competing endogenous RNA network: HOX transcript antisense intergenic RNA/miR-129-5p/brain and acute leukemia, cytoplasmic axis contributes to the malignant progression of esophageal squamous cell carcinoma.

Hui Cai, Haotian Jin, Diying Jiang, Xian Chen, Yuan Wang, Xiaomeng Sun, Ruoyu Zhang

Abstract read
In one paragraph

Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hui CaiDepartment of Healthcare and Geriatrics, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Haotian JinCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Diying JiangDepartment of Healthcare and Geriatrics, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Xian ChenDepartment of Healthcare and Geriatrics, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Yuan WangDepartment of Healthcare and Geriatrics, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Xiaomeng SunDepartment of Healthcare and Geriatrics, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.
Ruoyu ZhangDepartment of Healthcare and Geriatrics, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.ORCID https://orcid.org/0000-0001-6585-6385

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related mortality globally, characterized by high incidence, poor prognosis, and limited therapeutic options. While long non-coding RNAs (lncRNAs) and microRNAs have been implicated in ESCC pathogenesis through competing endogenous RNA (ceRNA) networks, the regulatory mechanisms underlying ferroptosis-related ceRNA interactions remain poorly defined. This study aimed to elucidate the functional role and molecular mechanism of the HOX transcript antisense intergenic RNA (HOTAIR)/miR-129-5p/brain and acute leukemia, cytoplasmic (BAALC) axis in ESCC progression. Methods: The regulatory relationship within the HOTAIR/miR-129-5p/ Results: Inhibition of Conclusions: This study unveils a novel ferroptosis-associated ceRNA regulatory axis in ESCC, demonstrating that HOTAIR promotes malignant progression by modulating the miR-129-5p/

Indexed as

brain and acute leukemia, cytoplasmic (BAALC)competing endogenous RNA (ceRNA)esophageal squamous cell carcinoma (ESCC)FerroptosisHOX transcript antisense intergenic RNA (HOTAIR)

Identifiers

PMID41969487
PMCPMC13066979

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.